BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 11866276)

  • 1. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission.
    Herrlinger KR; Noftz MK; Dalhoff K; Ludwig D; Stange EF; Fellermann K
    Am J Gastroenterol; 2002 Feb; 97(2):377-81. PubMed ID: 11866276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in pulmonary function in patients with ulcerative colitis.
    Mohamed-Hussein AA; Mohamed NA; Ibrahim ME
    Respir Med; 2007 May; 101(5):977-82. PubMed ID: 17049827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
    Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV
    Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
    Mittal RD; Bid HK; Ghoshal UC
    Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
    Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
    Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low prevalence of pulmonary involvement in children with inflammatory bowel disease.
    Peradzyńska J; Krenke K; Lange J; Banaszkiewicz A; Łazowska-Przeorek I; Radzikowski A; Kulus M
    Respir Med; 2012 Jul; 106(7):1048-54. PubMed ID: 22516040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of MALTectomy (appendectomy and tonsillectomy) and inflammatory bowel disease: a familial case-control study.
    López Ramos D; Gabriel R; Cantero Perona J; Moreno Otero R; Fernández Bermejo M; Maté Jiménez J
    Rev Esp Enferm Dig; 2001 May; 93(5):303-14. PubMed ID: 11488108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells.
    Baumgart DC; Metzke D; Schmitz J; Scheffold A; Sturm A; Wiedenmann B; Dignass AU
    Gut; 2005 Feb; 54(2):228-36. PubMed ID: 15647187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between smoking and Crohn's disease but the usual association with ulcerative colitis in Jewish patients in Israel: a multicenter study.
    Reif S; Lavy A; Keter D; Fich A; Eliakim R; Halak A; Broide E; Niv Y; Ron Y; Patz J; Odes S; Villa Y; Gilat T
    Am J Gastroenterol; 2000 Feb; 95(2):474-8. PubMed ID: 10685753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B
    Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibromyalgia in inflammatory bowel disease.
    Buskila D; Odes LR; Neumann L; Odes HS
    J Rheumatol; 1999 May; 26(5):1167-71. PubMed ID: 10332985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.
    Simrén M; Axelsson J; Gillberg R; Abrahamsson H; Svedlund J; Björnsson ES
    Am J Gastroenterol; 2002 Feb; 97(2):389-96. PubMed ID: 11866278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary complications in patients with inflammatory bowel disease.
    Kuzela L; Vavrecka A; Prikazska M; Drugda B; Hronec J; Senkova A; Drugdova M; Oltman M; Novotna T; Brezina M; Kratky A; Kristufek P
    Hepatogastroenterology; 1999; 46(27):1714-9. PubMed ID: 10430329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease.
    Czub E; Herzig KH; Szaflarska-Popawska A; Kiehne K; Socha P; Woś H; Kamińska B; Błaszczyński M; Cichy W; Bała G; Brodzicki J; Grzybowska-Chlebowczyk U; Walkowiak J
    Scand J Gastroenterol; 2007 Oct; 42(10):1147-50. PubMed ID: 17852864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
    Mokrowiecka A; Gasiorowska A; Małecka-Panas E
    Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Previous experience and quiality of life in patients with inflammatory bowel disease during relapse.
    Casellas F; López Vivancos J; Malagela JR
    Rev Esp Enferm Dig; 2003 Jul; 95(7):476-9, 471-5. PubMed ID: 12952508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
    Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease.
    Nielsen OH; Ciardelli T; Wu Z; Langholz E; Kirman I
    Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.